ASN-DRONEDARONE DIN 02514397
Status: Approved
Holder: ASCEND LABORATORIES LTD
Health Canada record
| Active ingredient(s) | DRONEDARONE (DRONEDARONE HYDROCHLORIDE) 400 MG |
|---|
| Dosage form | Tablet |
|---|
| Route | Oral |
|---|
| Schedule | PRESCRIPTION |
|---|
| Class | Human |
|---|
| ATC | C01BD07 DRONEDARONE |
|---|
| Original market date | |
|---|
| Current status date | 29-Mar-2021 |
|---|
| Source | Health Canada DPD |
|---|
Establishment licence of the holder
Ascend Laboratories Ltd — licence 3-002524, currently licensed, last inspection rating C (2024-04-25).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing DRONEDARONE (DRONEDARONE HYDROCHLORIDE)
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02330989 | MULTAQ | SANOFI-AVENTIS CANADA INC | Tablet | DRONEDARONE (DRONEDARONE HYDROCHLORIDE) 400 MG | Marketed |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 25532 | 2021-03-29 | Abbreviated New Drug Submission (ANDS) | |
Request a quote for ASN-DRONEDARONE
How to read a Canadian DIN record